Escalon Medical Corp. (ESMC)
OTCMKTS
· Delayed Price · Currency is USD
0.150
0.00 (0.00%)
Sep 25, 2024, 4:00 PM EDT
Escalon Medical Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Revenue | 11.65 | 12.18 | 10.7 | 10.47 | 9.4 | 9.63 | Upgrade
|
| Revenue Growth (YoY) | -2.60% | 13.80% | 2.21% | 11.40% | -2.35% | -15.57% | Upgrade
|
| Cost of Revenue | 6.51 | 6.7 | 6.1 | 6.04 | 5.2 | 5 | Upgrade
|
| Gross Profit | 5.13 | 5.48 | 4.61 | 4.43 | 4.2 | 4.63 | Upgrade
|
| Selling, General & Admin | 4.48 | 4.18 | 4.09 | 3.57 | 3.87 | 4.14 | Upgrade
|
| Research & Development | 0.69 | 0.82 | 0.99 | 0.89 | 1.12 | 0.74 | Upgrade
|
| Operating Expenses | 5.17 | 5 | 5.08 | 4.46 | 5 | 4.88 | Upgrade
|
| Operating Income | -0.04 | 0.48 | -0.47 | -0.03 | -0.79 | -0.25 | Upgrade
|
| Interest Expense | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.02 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 0 | 0 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | -0.06 | 0.46 | -0.49 | -0.05 | -0.8 | -0.25 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.61 | - | Upgrade
|
| Other Unusual Items | - | - | 0.51 | - | 0.76 | - | Upgrade
|
| Pretax Income | -0.06 | 0.46 | 0.02 | -0.05 | -0.65 | -0.25 | Upgrade
|
| Earnings From Continuing Operations | -0.06 | 0.46 | 0.02 | -0.05 | -0.65 | -0.25 | Upgrade
|
| Net Income | -0.06 | 0.46 | 0.02 | -0.05 | -0.65 | -0.25 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.24 | 0.24 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Net Income to Common | -0.3 | 0.22 | -0.03 | -0.1 | -0.7 | -0.3 | Upgrade
|
| Net Income Growth | - | 2426.55% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 14 | 7 | 7 | 7 | 7 | Upgrade
|
| Shares Change (YoY) | -38.01% | 82.92% | - | - | - | -18.88% | Upgrade
|
| EPS (Basic) | -0.04 | 0.03 | -0.00 | -0.01 | -0.09 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.04 | 0.03 | -0.00 | -0.01 | -0.09 | -0.04 | Upgrade
|
| Free Cash Flow | 0.06 | 0.32 | -1.05 | 0.83 | -0.23 | -0.49 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.02 | -0.14 | 0.11 | -0.03 | -0.07 | Upgrade
|
| Gross Margin | 44.07% | 45.00% | 43.04% | 42.28% | 44.70% | 48.09% | Upgrade
|
| Operating Margin | -0.33% | 3.93% | -4.39% | -0.32% | -8.45% | -2.63% | Upgrade
|
| Profit Margin | -2.55% | 1.82% | -0.31% | -0.99% | -7.47% | -3.13% | Upgrade
|
| Free Cash Flow Margin | 0.52% | 2.61% | -9.81% | 7.92% | -2.43% | -5.14% | Upgrade
|
| EBITDA | -0 | 0.52 | -0.42 | 0.01 | -0.74 | -0.2 | Upgrade
|
| EBITDA Margin | -0.00% | 4.30% | -3.94% | 0.11% | -7.92% | -2.11% | Upgrade
|
| D&A For EBITDA | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | Upgrade
|
| EBIT | -0.04 | 0.48 | -0.47 | -0.03 | -0.79 | -0.25 | Upgrade
|
| EBIT Margin | -0.33% | 3.93% | -4.39% | -0.32% | -8.45% | -2.63% | Upgrade
|
| Revenue as Reported | 11.65 | 12.18 | 10.7 | 10.47 | 9.4 | 9.63 | Upgrade
|
| Advertising Expenses | - | - | - | 0 | 0.02 | 0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.